PBE ETF holdings
Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
| Snapshot field | Reported value |
|---|
| Fund | Invesco Biotechnology & Genome ETF |
|---|
| Report date | 2026-04-30 |
|---|
| Reported holdings | 33 |
|---|
| SEC series ID | S000003026 |
|---|
Positions 1–33 of 33
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 10.916136% | 27,004,624.1924 | 27,001,924 NS |
|---|
| UTHR | United Therapeutics Corp. | 6.284829% | 15,547,576.2 | 27,212 NS |
|---|
| ILMN | Illumina, Inc. | 5.370793% | 13,286,407.68 | 104,832 NS |
|---|
| BIIB | Biogen Inc. | 5.051774% | 12,497,212 | 66,025 NS |
|---|
| INCY | Incyte Corp. | 4.910139% | 12,146,829.73 | 127,499 NS |
|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 4.842345% | 11,979,119.94 | 38,706 NS |
|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 4.76856% | 11,796,589.04 | 16,684 NS |
|---|
| AMGN | Amgen Inc. | 4.709975% | 11,651,658.75 | 33,651 NS |
|---|
| GILD | Gilead Sciences, Inc. | 4.615369% | 11,417,621.76 | 87,264 NS |
|---|
| Invesco Private Government Fund | Invesco Private Government Fund | 4.201173% | 10,392,972.42 | 10,392,972.42 NS |
|---|
| BCRX | BioCryst Pharmaceuticals, Inc. | 3.419349% | 8,458,875.28 | 923,458 NS |
|---|
| Catalyst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. | 3.303438% | 8,172,130.69 | 290,513 NS |
|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. | 3.278436% | 8,110,281.52 | 110,374 NS |
|---|
| PTGX | Protagonist Therapeutics, Inc. | 3.217151% | 7,958,672.55 | 80,415 NS |
|---|
| TGTX | TG Therapeutics, Inc. | 3.145215% | 7,780,716.3 | 230,335 NS |
|---|
| RPRX | Royalty Pharma PLC | 3.134206% | 7,753,481.19 | 154,791 NS |
|---|
| CDNA | CareDx, Inc. | 3.070952% | 7,597,002.65 | 365,065 NS |
|---|
| NBIX | Neurocrine Biosciences, Inc. | 2.856066% | 7,065,412.2 | 53,660 NS |
|---|
| EXEL | Exelixis, Inc. | 2.797942% | 6,921,621.72 | 155,682 NS |
|---|
| TECH | Bio-Techne Corp. | 2.728268% | 6,749,261.28 | 122,004 NS |
|---|
| PTCT | PTC Therapeutics, Inc. | 2.679298% | 6,628,117.62 | 101,877 NS |
|---|
| VCYT | Veracyte, Inc. | 2.620251% | 6,482,046.76 | 196,903 NS |
|---|
| ACAD | Acadia Pharmaceuticals Inc. | 2.59352% | 6,415,918.15 | 285,787 NS |
|---|
| VCEL | Vericel Corp. | 2.579326% | 6,380,803.98 | 183,726 NS |
|---|
| HALO | Halozyme Therapeutics, Inc. | 2.570254% | 6,358,360.8 | 99,880 NS |
|---|
| RGEN | Repligen Corp. | 2.495636% | 6,173,770.73 | 52,183 NS |
|---|
| TBPH | Theravance Biopharma Inc. | 2.494963% | 6,172,104.96 | 368,704 NS |
|---|
| IONS | Ionis Pharmaceuticals, Inc. | 2.485325% | 6,148,262.4 | 82,240 NS |
|---|
| BMRN | BioMarin Pharmaceutical Inc. | 2.445624% | 6,050,049.75 | 112,225 NS |
|---|
| COLL | Collegium Pharmaceutical, Inc. | 2.121267% | 5,247,645.94 | 155,578 NS |
|---|
| QGEN | Qiagen N.V. | 2.02544% | 5,010,585.93 | 144,898.3786 NS |
|---|
| MNKD | MannKind Corp. | 1.451139% | 3,589,866.32 | 1,268,504 NS |
|---|
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 0.05913% | 146,277.13 | 146,277.13 NS |
|---|